About Enveda
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from living organisms. By developing a comprehensive database of chemical biodiversity, Enveda aims to accelerate the discovery of new medicines.
Company details
Funding
Total raised
$530M
Last stage
Series D
Investors
Founders
Viswa Colluru
PhD in cellular and molecular biology from UW-Madison. Previously first Innovation Scientist and Product Manager at Recursion Pharmaceuticals. Built Enveda from $55k of personal savings into a clinical-stage unicorn. Named UBS Global Visionary in 2023.
LinkedInPieter Dorrestein
Co-founded Enveda in 2019 alongside Viswa Colluru. Known for work in metabolomics and natural product chemistry.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.